Crossmark Global Holdings Inc. Has $17.33 Million Holdings in Colgate-Palmolive Company (NYSE:CL)

Crossmark Global Holdings Inc. lifted its stake in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 6.4% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 184,977 shares of the company's stock after purchasing an additional 11,146 shares during the quarter. Crossmark Global Holdings Inc.'s holdings in Colgate-Palmolive were worth $17,332,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. Westend Capital Management LLC lifted its position in shares of Colgate-Palmolive by 111.1% during the 1st quarter. Westend Capital Management LLC now owns 266 shares of the company's stock worth $25,000 after buying an additional 140 shares during the last quarter. Vermillion Wealth Management Inc. bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth $31,000. Briaud Financial Planning Inc bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth $32,000. Wintrust Investments LLC bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth $33,000. Finally, Bernard Wealth Management Corp. bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth $33,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on CL shares. Wells Fargo & Company upped their price objective on Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a research report on Wednesday, April 2nd. Barclays dropped their target price on Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating for the company in a research report on Friday, April 11th. Piper Sandler dropped their target price on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating for the company in a research report on Monday, March 31st. JPMorgan Chase & Co. increased their target price on Colgate-Palmolive from $95.00 to $103.00 and gave the company an "overweight" rating in a research report on Monday, April 28th. Finally, Wall Street Zen downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat, Colgate-Palmolive currently has a consensus rating of "Hold" and an average price target of $101.69.

Colgate-Palmolive Trading Up 0.6%

NYSE CL traded up $0.60 during trading hours on Monday, hitting $93.38. 5,794,090 shares of the company's stock were exchanged, compared to its average volume of 4,816,411. The stock has a 50-day simple moving average of $90.61 and a 200 day simple moving average of $90.52. Colgate-Palmolive Company has a 1-year low of $85.32 and a 1-year high of $109.30. The firm has a market cap of $75.68 billion, a price-to-earnings ratio of 26.38, a PEG ratio of 4.93 and a beta of 0.37. The company has a current ratio of 0.85, a quick ratio of 0.54 and a debt-to-equity ratio of 8.96.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its earnings results on Friday, April 25th. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.86 by $0.05. Colgate-Palmolive had a return on equity of 461.04% and a net margin of 14.52%. The business had revenue of $4.91 billion during the quarter, compared to analysts' expectations of $4.92 billion. During the same quarter last year, the firm posted $0.86 earnings per share. The firm's revenue was down 3.0% on a year-over-year basis. On average, equities analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive announced that its board has approved a stock repurchase program on Thursday, March 20th that allows the company to buyback $5.00 billion in shares. This buyback authorization allows the company to reacquire up to 6.8% of its shares through open market purchases. Shares buyback programs are typically a sign that the company's board of directors believes its stock is undervalued.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Investors of record on Friday, July 18th will be paid a dividend of $0.52 per share. The ex-dividend date of this dividend is Friday, July 18th. This represents a $2.08 annualized dividend and a yield of 2.23%. Colgate-Palmolive's dividend payout ratio is currently 58.76%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.